Infliximab use in patients with Crohn's disease: quality of life, costs and resource use

Neth J Med. Jul-Aug 2006;64(7):212-8.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Cohort Studies
  • Crohn Disease / drug therapy*
  • Crohn Disease / economics
  • Crohn Disease / epidemiology
  • Drug Costs*
  • Europe / epidemiology
  • Gastrointestinal Agents / economics
  • Gastrointestinal Agents / therapeutic use*
  • Health Resources / economics
  • Health Resources / statistics & numerical data*
  • Humans
  • Infliximab
  • North America / epidemiology
  • Quality of Life*
  • Randomized Controlled Trials as Topic

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab